What's new?

Added 10 hours ago Drug news

Rozlytrek approved in Japan for NTRK fusion solid tumours.- Genentech/Roche

Genentech/Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek (entrectinib) for the treatment of adult...

Added 10 hours ago Drug news

Phase IIIb trial of Linzess meets endpoints in irritable bowel syndrome with constipation.- Ironwood Pharma/Allergan

Ironwood Pharmaceuticals and Allergan announced positive topline data from a Phase IIIb clinical trial evaluating Linzess (linaclotide) 290 mcg on...

Added 1 day ago Drug news

Abbott launches Afinion HbA1c Dx assay the first-ever rapid point-of-care HbA1c Test to aid in the diagnosis of diabetes.

Abbott announced that its Afinion HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well...

Added 1 day ago Drug news

FDA approves Keytruda to treat small cell lung cancer.- Merck Inc.

FDA has granted accelerated approval to pembrolizumab (Keytruda, Merck) for patients with metastatic small cell lung cancer (SCLC), marking the...

Added 1 day ago Drug news

Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer .-AstraZeneca + Merck Inc.

AstraZeneca and MSD Inc., announced that the European Commission (EC) has approved Lynparza (olaparib) as a 1st-line maintenance treatment for...